Alexander Jenke

Alexander Jenke is a prominent fund manager at Medical Strategy, a German investment firm specializing in healthcare. With a PhD in biology, Jenke has been actively analyzing the pharmaceutical and biotech sectors, particularly focusing on the recent surge in mergers and acquisitions. He notes that the regulatory environment in the US has improved, leading to increased M&A activity, which is crucial for large pharmaceutical companies facing patent expirations. His insights reflect a deep understanding of market dynamics and investment strategies within the healthcare landscape.